Vision Medicines
About:
Vision Medicines is a promising drug candidate to treat Stargardt disease.
Website: http://visionmedicines.com/
Description:
Vision Medicines has a promising drug candidate to treat Stargardt disease, a rare genetic retinal degenerative disease, and other rare diseases caused by inborn errors of aldehyde metabolism. Vision Medicines has recruited a world-class scientific advisory board that includes leading scientists and clinicians specializing in retinal biology and genetics.
Total Funding Amount:
$7.5M
Headquarters Location:
Cambridge, Massachusetts, United States
Founded Date:
2013-01-01
Founders:
Brinda Balakrishnan, Chris Varma, Reza Dana
Number of Employees:
11-50
Last Funding Date:
2015-11-09
IPO Status:
Private
Industries:
© 2025 bioDAO.ai